Literature DB >> 25043401

Long-term outcome after parathyroidectomy for lithium-induced hyperparathyroidism.

O Norlén1, S Sidhu, M Sywak, L Delbridge.   

Abstract

BACKGROUND: The accepted management of lithium-associated hyperparathyroidism (LiHPT) is open four-gland parathyroid exploration (OPTX). This approach has recently been the subject of controversy. A recent study has shown very high long-term recurrence rates after OPTX, whereas some have promoted unilateral focused parathyroidectomy as appropriate management. The aim was to evaluate long-term outcomes after surgery for LiHPT and to assess the accuracy of preoperative imaging.
METHODS: This was a retrospective cohort study that comprised all patients undergoing initial surgery for LiHPT between 1990 and 2013. The cumulative recurrence rate was calculated by the Kaplan-Meier method. The sensitivity and specificity of sestamibi scintigraphy and ultrasound imaging for identification of single-gland versus multigland disease was investigated using intraoperative assessment as reference.
RESULTS: Of 48 patients, 45 had OPTX and three underwent focused parathyroidectomy. Multiglandular disease was documented in 27 patients and 21 had a single adenoma. The median follow-up was 5·9 (range 0·3-22) years and 16 patients died during follow-up. The 10-year cumulative recurrence rate was 16 (95 per cent confidence interval 2 to 29) per cent. No permanent complications occurred after primary surgery for LiHPT. Twenty-four patients had at least one preoperative ultrasound or sestamibi scan. For concordant sestamibi scintigraphy and ultrasound imaging, the sensitivity and specificity for identifying single-gland versus multigland disease was five of nine and five of eight respectively.
CONCLUSION: Surgery provided a safe and effective management option for patients with LiHPT in this series, with a long-term cure rate of well over 80 per cent.
© 2014 BJS Society Ltd. Published by John Wiley & Sons Ltd.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25043401     DOI: 10.1002/bjs.9589

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  5 in total

1.  Three Patients with Lithium-Associated Hyperparathyroidism: Literature Review Regarding Medical and Surgical Management.

Authors:  Ramy M Hanna; Huma Hasnain; Michelle D Sangalang; Jennifer Han; Aarthi Arasu; Farid Arman; Marina Barsoum; Hyunah Poa; Anjay Rastogi; Avital Harari
Journal:  Case Rep Nephrol Dial       Date:  2019-08-20

Review 2.  The Role of Lithium in Management of Endocrine Tumors-A Comprehensive Review.

Authors:  Shilpa Thakur; Andrew Tobey; Joanna Klubo-Gwiezdzinska
Journal:  Front Oncol       Date:  2019-10-18       Impact factor: 6.244

Review 3.  Sporadic multiple parathyroid gland disease--a consensus report of the European Society of Endocrine Surgeons (ESES).

Authors:  Marcin Barczyński; Robert Bränström; Gianlorenzo Dionigi; Radu Mihai
Journal:  Langenbecks Arch Surg       Date:  2015-11-05       Impact factor: 3.445

4.  Lithium-Associated Hypercalcemia: Pathophysiology, Prevalence, Management.

Authors:  Adrian D Meehan; Ruzan Udumyan; Mathias Kardell; Mikael Landén; Johannes Järhult; Göran Wallin
Journal:  World J Surg       Date:  2018-02       Impact factor: 3.352

Review 5.  The New News about Lithium: An Underutilized Treatment in the United States.

Authors:  Robert M Post
Journal:  Neuropsychopharmacology       Date:  2017-10-04       Impact factor: 7.853

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.